 |
afatinib |
|---|---|
| Trade Name | Gilotrif(R) |
| Orphan Indication | Non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2015-08-03 00:00:00 |
| Sponsor | Boehringer Ingelheim Pharmaceuticals, Inc.;900 Ridgebury Road, P. O. Box 368;Ridgefield, Connecticut, 06877 |
Related Access Program